Opioid Use Disorder Diagnoses Rose Nearly 33 Percent Among Commercially Insured Patients From 2022 to 2025
The number of commercially insured patients receiving diagnoses of opioid use disorder climbed 32.7 percent nationally between 2022 and 2025, ...
